» Articles » PMID: 15845492

Boosting of DNA Vaccine-elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites

Abstract

A mixture of DNA plasmids expressing five Plasmodium falciparum pre-erythrocyte-stage antigens was administered with or without a DNA plasmid encoding human granulocyte-macrophage colony-stimulating factor (hGM-CSF) as an immune enhancer. After DNA immunization, antigen-specific gamma interferon (IFN-gamma) responses were detected by ELISPOT in 15/31 volunteers to multiple class I- and/or class II-restricted T-cell epitopes derived from all five antigens. Responses to multiple epitopes (</=7) were detected simultaneously in some volunteers. By 4 weeks after challenge with P. falciparum parasites, 23/31 volunteers had positive IFN-gamma responses and the magnitude of responses was increased from 2- to 143-fold. Nonetheless, none was protected against malaria. Volunteers who received hGM-CSF had a reduced frequency of IFN-gamma responses to class I peptides compared to those who only received plasmids expressing P. falciparum proteins before challenge (3/23 versus 3/8; P = 0.15) or after parasite challenge (4/23 versus 5/8; P = 0.015) but not to class II peptides before or after challenge. The responses to one antigen (P. falciparum circumsporozoite protein [PfCSP]) were similar among volunteers who received the five-gene mixture compared to volunteers who only received the PfCSP DNA plasmid in a previous study. In summary, DNA-primed IFN-gamma responses were boosted in humans by exposure to native antigen on parasites, coadministration of a plasmid expressing hGM-CSF had a negative effect on boosting of class I-restricted IFN-gamma responses, and there was no evidence that immunization with PfCSP DNA in the mixture reduced T-cell responses to PfCSP compared to when it was administered alone.

Citing Articles

Stereo electronic principles for selecting fully-protective, chemically-synthesised malaria vaccines.

Patarroyo M, Bermudez A, Alba M, Patarroyo M, Suarez C, Aza-Conde J Front Immunol. 2022; 13:926680.

PMID: 36341338 PMC: 9630920. DOI: 10.3389/fimmu.2022.926680.


A three-antigen Plasmodium falciparum DNA prime-Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults.

Sklar M, Maiolatesi S, Patterson N, Sedegah M, Limbach K, Teneza-Mora N PLoS One. 2021; 16(9):e0256980.

PMID: 34495988 PMC: 8425539. DOI: 10.1371/journal.pone.0256980.


Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute Malaria.

Heide J, Wildner N, Ackermann C, Wittner M, Marget M, Sette A Front Immunol. 2020; 10:3037.

PMID: 32038611 PMC: 6993587. DOI: 10.3389/fimmu.2019.03037.


Comprehensive Review of Human -Specific CD8+ T Cell Epitopes.

Heide J, Vaughan K, Sette A, Jacobs T, Schulze Zur Wiesch J Front Immunol. 2019; 10:397.

PMID: 30949162 PMC: 6438266. DOI: 10.3389/fimmu.2019.00397.


Controlled Human Malaria Infection: Applications, Advances, and Challenges.

Stanisic D, McCarthy J, Good M Infect Immun. 2017; 86(1).

PMID: 28923897 PMC: 5736798. DOI: 10.1128/IAI.00479-17.


References
1.
Wang R, Epstein J, Baraceros F, Gorak E, Charoenvit Y, Carucci D . Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. Proc Natl Acad Sci U S A. 2001; 98(19):10817-22. PMC: 58557. DOI: 10.1073/pnas.181123498. View

2.
Parker S, Monteith D, Horton H, Hof R, Hernandez P, Vilalta A . Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine. Gene Ther. 2001; 8(13):1011-23. DOI: 10.1038/sj.gt.3301491. View

3.
Richie T, Saul A . Progress and challenges for malaria vaccines. Nature. 2002; 415(6872):694-701. DOI: 10.1038/415694a. View

4.
Kumar S, Epstein J, Richie T, Nkrumah F, Soisson L, Carucci D . A multilateral effort to develop DNA vaccines against falciparum malaria. Trends Parasitol. 2002; 18(3):129-35. DOI: 10.1016/s1471-4922(01)02207-3. View

5.
Hoffman S, Goh L, Luke T, Schneider I, Le T, Doolan D . Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. J Infect Dis. 2002; 185(8):1155-64. DOI: 10.1086/339409. View